Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
319.00    10.00 (3.24%)
Bid:
308.00
Ask:
319.00
Spread: 11.00 (3.571%)
Market Cap: £183.67m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Investment Presentation

2 Dec 2022 07:00

RNS Number : 3227I
Liontrust Asset Management PLC
02 December 2022
Β 

LEI: 549300XVXU6S7PLCL855

FOR IMMEDIATE RELEASE

2 December 2022

Β 

Stock Exchange Announcement

LIONTRUST ASSET MANAGEMENT PLC

Investor Presentation

Β 

Liontrust Asset Management Plc ("Liontrust") is pleased to announce that John Ions and Vinay Abrol will provide a live presentation on its Half Year Report for the six months ended 30 September 2022 via the Investor Meet Company platform on 8 December 2022 at 10:30 a.m.

Β 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9 a.m. the day before the meeting or at any time during the live presentation.

Β 

Investors can sign up to Investor Meet Company for free and add to meet Liontrust via:

Β 

https://www.investormeetcompany.com/liontrust-asset-management-plc/register-investor

Β 

Investors who already follow Liontrust on the Investor Meet Company platform will automatically be invited.

Β 

For further information please contact:

Β 

Tulchan Communications (Tel: 020 7353 4200, Email: liontrust@tulchangroup.com)

Tom Murray or Stephanie Mackrell

Β 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

John Ions: Chief Executive

Vinay Abrol: Chief Financial Officer & Chief Operating Officer

Simon Hildrey: Chief Marketing Officer

David Boyle: Head of Corporate Development

Β 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Tom Salvesen

Corporate Finance: Justin McKeegan

Β 

Panmure Gordon (Tel: 020 7886 2500)

Corporate Broking: Charles Leigh-Pemberton

Corporate Advisory: Dominic Morley

Β 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDFLFVEFDLLIIF
Date   Source Headline
1st Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAppointment of Joint Corporate Broker
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:36 amRNSTotal Voting Rights
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20261:28 pmRNSForm 8.3 - ESSENSYS
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20262:29 pmRNSForm 8.3 - ESSENSYS PLC
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:40 pmRNSForm 8.3 - Kitwave group plc
18th Feb 20262:37 pmRNSForm 8.3 - Oxford Biomedica Plc
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:20 pmRNSForm 8.3 - ESSENSYS PLC
17th Feb 20263:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
16th Feb 20262:51 pmRNSForm 8.3 - Oxford Biomedica Plc
13th Feb 202610:13 amRNSHolding(s) in Company
13th Feb 202610:11 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 202611:15 amRNSForm 8.3 - KITWAVE GROUP PLC
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:07 pmRNSForm 8.3 - Kitwave Group Plc
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:25 pmRNSForm 8.3 - KITWAVE GROUP PLC
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20262:27 pmRNSForm 8.3 - Kitwave group plc
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.